Zypadhera 300 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 300 mg + 3 ml
Active ingredient: Olanzapine
View notice details →
News topic
All current shortage notices related to Reason: Logistische Probleme (Transport, Zoll usw.), structured by product, country, active ingredient and reporting period.
9 noticesThe 9 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Active ingredient: Olanzapine
View notice details →Active ingredient: Olanzapine
View notice details →Active ingredient: Midazolam
View notice details →Active ingredient: Ethinylestradiol; Gestodene
View notice details →Active ingredient: Ethinylestradiol; Gestodene
View notice details →Active ingredient: Ethinylestradiol; Levonorgestrel
View notice details →Active ingredient: Ethinylestradiol; Norelgestromin
View notice details →Active ingredient: Colchicine
View notice details →Active ingredient: Progesterone
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →